<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="article-commentary" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Health Syst Pharm</journal-id><journal-id journal-id-type="iso-abbrev">Am J Health Syst Pharm</journal-id><journal-id journal-id-type="pmc-domain-id">3648</journal-id><journal-id journal-id-type="pmc-domain">ajhp</journal-id><journal-id journal-id-type="publisher-id">ajhp</journal-id><journal-title-group><journal-title>American Journal of Health-System Pharmacy: AJHP</journal-title></journal-title-group><issn pub-type="ppub">1079-2082</issn><issn pub-type="epub">1535-2900</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11701109</article-id><article-id pub-id-type="pmcid-ver">PMC11701109.1</article-id><article-id pub-id-type="pmcaid">11701109</article-id><article-id pub-id-type="pmcaiid">11701109</article-id><article-id pub-id-type="pmid">39324578</article-id><article-id pub-id-type="doi">10.1093/ajhp/zxae266</article-id><article-id pub-id-type="publisher-id">zxae266</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Commentaries</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00410</subject></subj-group></article-categories><title-group><article-title>Collaborative pharmacy research across integrated health systems: A purpose and promise for opportunities to study the complete medication-use process</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Olson</surname><given-names initials="AW">Anthony W</given-names></name><degrees>PhD, PharmD</degrees><aff>
<institution>Research Division, Essentia Institute of Rural Health, Duluth, MN, and Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota</institution>, <addr-line>Duluth, MN</addr-line>, <country country="US">USA</country></aff><xref rid="c1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Miller</surname><given-names initials="MJ">Michael J</given-names></name><degrees>RPh, DrPH, FAPhA</degrees><aff>
<institution>Mid-Atlantic Permanente Research Institute</institution>, <addr-line>Rockville, MD</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pawloski</surname><given-names initials="PA">Pamala A</given-names></name><degrees>PharmD, BCOP, FCCP</degrees><aff>
<institution>HealthPartners Institute, Bloomington, MN, and Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota</institution>, <addr-line>Minneapolis, MN</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Waring</surname><given-names initials="SC">Stephen C</given-names></name><degrees>DVM, PhD</degrees><aff>
<institution>Research Division, Essentia Institute of Rural Health, Duluth, MN, and Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota</institution>, <addr-line>Duluth, MN</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kuntz</surname><given-names initials="JL">Jennifer L</given-names></name><degrees>PhD</degrees><aff>
<institution>Kaiser Permanente Center for Health Research</institution>, <addr-line>Portland, OR</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="X">Xiaojuan</given-names></name><degrees>PhD, MSPH</degrees><aff>
<institution>Department of Population Medicine, Harvard Medical School, Boston, MA, and Harvard Pilgrim Health Care Institute</institution>, <addr-line>Boston, MA</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wong</surname><given-names initials="J">Jenna</given-names></name><degrees>PhD, MSc</degrees><aff>
<institution>Department of Population Medicine, Harvard Medical School, Boston, MA, and Harvard Pilgrim Health Care Institute</institution>, <addr-line>Boston, MA</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wright</surname><given-names initials="EA">Eric A</given-names></name><degrees>PharmD, MPH</degrees><aff>
<institution>Center for Pharmacy Innovation &amp; Outcomes</institution>, <addr-line>Geisinger, Scranton, PA</addr-line>, and Department of Bioethics and Decision Sciences and Department of Pharmacy, College of Health Sciences, <addr-line>Scranton, PA</addr-line>, <country country="US">USA</country></aff></contrib></contrib-group><author-notes><corresp id="c1">Address correspondence to Dr. Olson (<email>anthony.olson@essentiahealth.org</email>).</corresp></author-notes><pub-date pub-type="collection"><day>15</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-10-14"><day>14</day><month>10</month><year>2024</year></pub-date><volume>82</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">478594</issue-id><fpage>120</fpage><lpage>126</lpage><history><date date-type="corrected-typeset"><day>14</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>14</day><month>10</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>07</day><month>01</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-07 00:25:15.707"><day>07</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; American Society of Health-System Pharmacists 2024.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="zxae266.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zxae266.pdf"/><kwd-group><kwd>integrated health systems</kwd><kwd>managed care organizations</kwd><kwd>medication-use process</kwd><kwd>outcomes research</kwd><kwd>research methods</kwd><kwd>research networks</kwd></kwd-group><counts><page-count count="7"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Prescription medications are commonly used to help diagnose, prevent, treat, and manage disease. Advancements in drug design, development, and clinical monitoring continue to contribute to decreased morbidity and mortality as well as improved quality of life for patients across the spectrum of diseases.<sup><xref rid="CIT0001" ref-type="bibr">1-4</xref></sup> Nearly two-thirds of US adults took at least one prescription medication in 2022, and 25% were taking 4 or more.<sup><xref rid="CIT0005" ref-type="bibr">5</xref></sup> Further, US adults obtained 6.4 billion prescriptions in 2022, accounting for ~10% (more than $4 billion) of healthcare expenditures.<sup><xref rid="CIT0006" ref-type="bibr">6</xref>,<xref rid="CIT0007" ref-type="bibr">7</xref></sup> Importantly, these costs do not reflect the unintended harmful events associated with normal use of medications (ie, adverse drug events, or ADEs).<sup><xref rid="CIT0008" ref-type="bibr">8</xref></sup> ADEs are responsible for roughly 5 million emergency department visits annually and by some estimates are the third most common cause of death in the US behind heart disease and cancer.<sup><xref rid="CIT0009" ref-type="bibr">9-12</xref></sup> Approximately half of ADEs are believed to be preventable.<sup><xref rid="CIT0013" ref-type="bibr">13</xref></sup></p><p>The importance and value of prescription medications are tied to their ubiquity, cost, and potential benefits and harms. These key domains contain critical unresolved research questions around the medication-use process (MUP) relevant to policy and practice.<sup><xref rid="CIT0014" ref-type="bibr">14</xref></sup><xref rid="F1" ref-type="fig">Figure 1</xref> consolidates prominent MUP models, consisting of 4 key domains of (de)prescribing/transcribing, preparing/dispensing, taking/administering, and monitoring/follow-up.<sup><xref rid="CIT0015" ref-type="bibr">15-18</xref></sup> Selection/procurement, safe storage, and disposal/waste are also important elements within the process.<sup><xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0017" ref-type="bibr">17</xref>,<xref rid="CIT0019" ref-type="bibr">19</xref>,<xref rid="CIT0020" ref-type="bibr">20</xref></sup> Each of these domains and elements generates important research questions.</p><fig position="float" id="F1" orientation="portrait"><label>Figure 1.</label><caption><p>Merged medication-use process (adapted from multiple sources).<sup><xref rid="CIT0015" ref-type="bibr">15-20</xref></sup> Rectangular shapes correspond to the domains most commonly represented across all medication-use process frameworks. Oval shapes are elements with ties to several of the cycle domains and inherently adjacent to their activities. FDA indicates Food and Drug Administration.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="zxae266_fig1.jpg"/></fig><p>Numerous translational studies have focused on the aforementioned MUP domains and elements to enhance practice, patient-clinician communication, and the medication-use experience.<sup><xref rid="CIT0021" ref-type="bibr">21-26</xref></sup> Several important MUP-based studies were conducted by practice-based research networks led by academic pharmacy<sup><xref rid="CIT0027" ref-type="bibr">27-29</xref></sup> and clinically integrated practice networks of independent/small-chain pharmacies.<sup><xref rid="CIT0030" ref-type="bibr">30</xref></sup> These important contributions advancing MUP research have been challenged by several limitations. All research and practice networks face challenges of funding network activities, training staff to conduct collaborations, and protecting time for clinicians and researchers to engage in research activities. Academic-based and independent/small-chain pharmacy networks have additional barriers to overcome such as developing processes for primary data collection (eg, identification, recruitment, and enrollment of study participants from numerous geographically dispersed organizations); ensuring the accuracy, completeness, and standardization of data and obtaining funding to acquire secondary databases (eg, administrative or claims); and addressing the unique requirements, goals, and needs of member sites (eg, data storage, access, ownership, and relevance to mission).<sup><xref rid="CIT0031" ref-type="bibr">31-36</xref></sup> While technology-driven solutions can help mitigate these challenges,<sup><xref rid="CIT0037" ref-type="bibr">37</xref></sup> sizable gaps remain in understanding the complex evidence enabling timely and informed ways to address persisting real-world MUP problems.<sup><xref rid="CIT0001" ref-type="bibr">1</xref>,<xref rid="CIT0015" ref-type="bibr">15</xref>,<xref rid="CIT0022" ref-type="bibr">22</xref>,<xref rid="CIT0038" ref-type="bibr">38-42</xref></sup></p><p>Since the 1990s, the US government has supported the formation and development of several research consortia embedded in collaborative and integrated community-based health systems. These collaborations have successfully addressed key gaps in research areas,<sup><xref rid="CIT0043" ref-type="bibr">43</xref></sup> including in cancer,<sup><xref rid="CIT0044" ref-type="bibr">44</xref>,<xref rid="CIT0045" ref-type="bibr">45</xref></sup> cardiovascular disease,<sup><xref rid="CIT0035" ref-type="bibr">35</xref></sup> integrated care models,<sup><xref rid="CIT0046" ref-type="bibr">46</xref></sup> mental health,<sup><xref rid="CIT0047" ref-type="bibr">47</xref>,<xref rid="CIT0048" ref-type="bibr">48</xref></sup> and postmarketing surveillance of drugs, devices, and vaccines.<sup><xref rid="CIT0049" ref-type="bibr">49-54</xref></sup> Many of these initiatives were not led by pharmacists and pharmacy-based researchers, despite their formal training, expertise, and experience in the MUP. Research networks among integrated health systems can complement and collaborate with existing academic and practice networks to address challenges, barriers, and gaps in MUP research. Additionally, pharmacists and pharmacy-based researchers of varying backgrounds embedded in health systems are increasingly tasked by health-system leadership with operationalizing medication optimization methods. Thus, pharmacists and pharmacy-based researchers are well positioned to lead these collaborative efforts and drive needed change for medication therapy optimization. This commentary aims to (1) describe the purpose and promise of health system&#8211;based research networks with a focus on the MUP; (2) outline the pathway for the development of and participation in one such consortium; and (3) identify foreseeable challenges critical for this initiative to overcome.</p><sec disp-level="2" id="s2"><title>Purpose and promise.</title><p>Health-system research networks, often integrated with insurance providers and payors, have inherent advantages for conducting rigorous, multicenter, community-based MUP research of interest to extramural funders and policymakers.<sup><xref rid="CIT0043" ref-type="bibr">43</xref>,<xref rid="CIT0044" ref-type="bibr">44</xref></sup> First, these networks generate data (1) collected through dynamic electronic health records (EHRs) and stored in research-ready data warehouses; (2) from large and diverse populations beyond those available at a single health system; (3) from stable populations (ie, patients are more likely to enroll and remain in studies conducted at their home health systems or integrated health plans); (4) across transitions between outpatient and inpatient care; and (5) representing real-world medication use.<sup><xref rid="CIT0045" ref-type="bibr">45</xref>,<xref rid="CIT0055" ref-type="bibr">55</xref></sup></p><p>Second, many health systems have embedded research teams, centers, and institutes that provide critical support, inspiration, and outlets for research collaborations.<sup><xref rid="CIT0043" ref-type="bibr">43</xref>,<xref rid="CIT0056" ref-type="bibr">56</xref></sup> As such, they are dedicated to rapidly identifying research questions and designs of practical and timely significance, quickly responding to funding opportunities, and seamlessly translating findings and effective interventions into practice. The nature of embedded research teams facilitates early and frequent collaboration among practitioners, administrators, and scientists. These teams use real-world data to identify care gaps and inform interventions to meet the needs of patients within the existing workflows of health systems, providers, and payors. This structure also enables collaborations across integrated health systems. Thus, a multi-stakeholder alignment of integrated health-system research networks benefits both individual health systems and the overall consortium, given that many have similar goals and philosophies, challenges, resource environments, infrastructure, and other characteristics.<sup><xref rid="CIT0043" ref-type="bibr">43</xref>,<xref rid="CIT0044" ref-type="bibr">44</xref>,<xref rid="CIT0057" ref-type="bibr">57</xref></sup></p><p>Third, integrated research networks use common data models (CDMs), which standardize the organization, coding structures, and variable definitions of datasets to support distributed processing of data.<sup><xref rid="CIT0058" ref-type="bibr">58-61</xref></sup> CDMs enable consistent measurement and analysis of patient (eg, race/ethnicity and health-related social needs), intervention, and outcome (eg, care quality, quality of life, cost-effectiveness, and subpopulations) variables over long time horizons because patients are more likely to remain with the same health system over time.<sup><xref rid="CIT0043" ref-type="bibr">43</xref></sup> These measurement qualities are useful to study topic areas such as the ever-changing and perplexing intersection of medication selection and reimbursement policies, finding and acquiring medications, and making medications available to the individuals or groups who need them. CDMs also enable EHR-sourced data to be efficiently used across different sites for short-term pilot and cross-sectional studies as well as longer-term and longitudinal cohort studies<sup><xref rid="CIT0062" ref-type="bibr">62-65</xref></sup> and interventional pragmatic studies.<sup><xref rid="CIT0066" ref-type="bibr">66-69</xref></sup> Similarly, use of a CDM across integrated networks expands generalizability through more complete and consistent capture of the numerous data variables related to medications, patients, providers, and health systems throughout the MUP that may influence therapeutic plans and outcomes.</p><p>The scope of most MUP studies is limited by the amount and type of data available to researchers. The results are understandings that may be partial at best and inaccurate at worst, and such studies are also limited by an inability to study rare medical conditions or ADEs. For example, studies on the prescribing or ordering process often do not account for any aspect of administration, medication adherence, monitoring, or outcomes. Claims-based studies focus on filled prescriptions and do not consider prescribing and primary or secondary medication adherence.<sup><xref rid="CIT0070" ref-type="bibr">70-72</xref></sup> Moreover, claims-based studies are often historical and do not allow for communication with providers or current patients to gain in-depth insight into the medication-use experience. Claims-only studies often lack the richness of medical and laboratory record data captured within EHRs, such as indication, therapeutic effectiveness, safety, and convenience/adherence documented from medication therapy management services provided by pharmacists. Making decisions impacting medication policy based on incomplete information may lead to misinformed decisions, suboptimal outcomes, and/or unintended consequences.</p><p>The overarching value of research within an integrated health-system network is the ability to study the entire medication-use continuum in a scalable and generalizable way through access to combined historical, real-time, and prospective patient data when they are most relevant and useful. In addition, a properly structured CDM enables researchers, practitioners, and patients to answer multiple medication-related research questions without recreating infrastructure for each individual research project or public health surveillance initiative (eg, surveillance of ADEs by the Food and Drug Administration Sentinel Initiative).<sup><xref rid="CIT0036" ref-type="bibr">36</xref>,<xref rid="CIT0053" ref-type="bibr">53</xref>,<xref rid="CIT0073" ref-type="bibr">73</xref></sup> A similar approach can be taken to conduct research in all domains of the MUP, such as when assessing the following:</p><list list-type="bullet"><list-item><p>
<bold>(De)prescribing/transcribing:</bold> collaborative practice agreements, biomedical informatics in clinical decision-making, comprehensive medication management</p></list-item><list-item><p>
<bold>Preparing/dispensing:</bold> medication synchronization, pharmacy workflows (eg, robotics, point-of-care vending for inpatients), mail-order pharmacy</p></list-item><list-item><p>
<bold>Taking/administering:</bold> socio-behavioral aspects of medication (eg, medication adherence, medication experience), drug infusion services, site of care, pharmacoepidemiology (eg, drug utilization)</p></list-item><list-item><p>
<bold>Monitoring/follow-up:</bold> pharmacovigilance, medication therapy management, pharmacoepidemiology (eg, comparative safety and effectiveness)</p></list-item><list-item><p>
<bold>Selection/procurement:</bold> pharmacoeconomics and policy (eg, specialty drugs, drug formulary management, contracting/pricing, drug shortages/supply chain issues)</p></list-item><list-item><p>
<bold>Safe storage:</bold> risk evaluation, drug security/diversion mitigation</p></list-item><list-item><p>
<bold>Disposal/waste:</bold> public health, drug disposal programs, environmental impact</p></list-item></list></sec><sec disp-level="2" id="s3"><title>Connecting pharmacy research through the Health Care Systems Research Network.</title><p>One of the largest networks of research centers embedded within health systems is the Health Care Systems Research Network (HCSRN), founded in 1994 and formerly known as the HMO Research Network.<sup><xref rid="CIT0036" ref-type="bibr">36</xref>,<xref rid="CIT0043" ref-type="bibr">43</xref>,<xref rid="CIT0057" ref-type="bibr">57</xref></sup> The organization is composed of 20 unique nonprofit integrated health systems providing healthcare for over 20 million US patients and connects data and researchers across institutions. The HCSRN generates public domain research, representing over 400 million person-years and in some cases extending back to 1958 (<xref rid="F2" ref-type="fig">Figure 2</xref>).<sup><xref rid="CIT0074" ref-type="bibr">74</xref></sup> The HCSRN developed a first-of-its-kind CDM, the Virtual Data Warehouse (VDW), complemented by streamlined administrative processes that include institutional review board ceding, standardized data use agreements and research oversight, and shared resources and capabilities to efficiently collaborate on research to improve individual and population health for all. The network is made up of over 2,000 multidisciplinary research scientists and research staff at its member organizations, with scientific interest groups in aging, cancer, mental health, patient engagement, research administration, and, most recently, pharmacy.</p><fig position="float" id="F2" orientation="portrait"><label>Figure 2.</label><caption><p>Locations and names of Health Care Systems Research Network (HCSRN) health-system members.<sup><xref rid="CIT0074" ref-type="bibr">74</xref></sup> Used with permission of HCSRN.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="zxae266_fig2.jpg"/></fig><p>The pharmacy scientific interest group (PhIG) was founded in 2022 and formed a workgroup to better organize the pharmacy-related data captured in HCSRN&#8217;s VDW. The purpose of HCSRN&#8217;s PhIG is to bring together individuals with expertise in pharmacy-related care, health outcomes, epidemiology, health services, implementation science, data management (eg, extraction, transformation, and loading) and analysis, and other disciplines who have an interest in sustainably exploring, evaluating, and improving medication-use data and processes. Consistent with the mission of the HCSRN, the PhIG aims to be as inclusive as is meaningfully possible. Participants from non-HCSRN member institutions are invited to join, and eligibility is not limited to pharmacists, pharmacy technicians, or solely pharmacy-specific researchers (inquiries may be sent to PhIG@hcsrn.org). PhIG&#8217;s immediate strategic goals are to (1) conduct ongoing VDW data enhancement and development of capabilities to capitalize on group member strengths and interests in pharmacy-related research and then (2) leverage the resulting functionality to disseminate research aligned with the group&#8217;s mission. Once these goals are achieved, PhIG&#8217;s strategic goal will shift to supporting established research subgroups pursuing and obtaining funding from federal and other extramural sources (eg, foundations) to sustain larger-scale projects.</p></sec><sec disp-level="2" id="s4"><title>Navigating key challenges.</title><p>Realizing the promise of collaborative pharmacy research across integrated health systems requires awareness of and mitigation of at least 3 key challenges. First, the collaboration needs to benefit all intra- and interorganizational stakeholders and yield research results that are important and relevant to health systems, health plans, provider groups, research cohorts, patients, families, and communities. Views about how to best use and share data and stakeholder resources (eg, protection of clinician time for research and investments in infrastructure, technology, and staff) may not uniformly overlap. Substantial time and effort must be devoted to collectively aligning interests and incentives to preserve a culture and environment that promotes collaboration and pursuit of sustainable research funding while also producing meaningful knowledge relevant to stakeholders.</p><p>Second, the fast-changing nature of clinical, operational, and research environments requires continual vigilance, communication, and adaptation among participating members. The impact of changes to practice guidelines, payor policies, leadership structures, rules and laws, market dynamics, and other variables has complex and far-reaching implications that require ongoing and effective information sharing and decision synchronization. This also represents an opportunity for a functional research network.</p><p>Third, recruitment, coordination, and sustained engagement of researchers with aligned interests and goals in MUP research is another challenge. An effective research network must balance the niche of constituent interests with the most important and relevant MUP knowledge and implementation gaps prioritized by patients, providers, policymakers, and other key stakeholders.</p></sec><sec disp-level="2" id="s5"><title>Conclusion and call to action.</title><p>Collaborations with embedded researchers within integrated community-based health systems, such as HCSRN, offer established research structures and real-world data that can address important research gaps. HCSRN&#8217;s PhIG provides a ready and available avenue for pharmacy-related researchers to participate in pharmacy research across integrated health systems. We invite interested parties to contact us at PhIG@hcsrn.org.</p></sec></body><back><ack id="a1"><title>Acknowledgments</title><p>The authors thank the Health Care System Research Network, its member institutions, and the following individuals for their expertise and assistance in the development of this commentary: Jaejin An, PhD, Mark Jurkovich, DDS, Michael Breslin, MBA, and Suzanne Simmons, MS.</p></ack><sec id="s6"><title>Disclosures</title><p>Dr. Wright and Dr. Waring serve on the board of the Health Care System Research Network. Dr. Miller serves as senior associate editor for the <italic toggle="yes">American Journal of Health-System Pharmacy</italic>. Dr. Li receives research support from the National Institute on Aging - National Institute of Health (K01AG073651). The remaining authors have declared no potential conflicts of interest.</p></sec><ref-list id="r1"><title>References</title><ref id="CIT0001"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lichtenberg</surname><given-names>FR.</given-names></string-name></person-group><article-title>The impact of pharmaceutical innovation on premature mortality, hospital separations, and cancer survival in Australia</article-title>. <source>Econ Rec</source>. <year>2017</year>;<volume>93</volume>(<issue>302</issue>):<fpage>353</fpage>-<lpage>378</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1111/1475-4932.12332</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lichtenberg</surname><given-names>FR.</given-names></string-name></person-group><article-title>The effect of pharmaceutical innovation on longevity: evidence from the U.S. and 26 high-income countries</article-title>. <source>Econ Hum Biol</source>. <year>2022</year>;<volume>46</volume>:<fpage>101124</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1016/J.EHB.2022.101124</pub-id><pub-id pub-id-type="pmid">35344806</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lichtenberg</surname><given-names>FR.</given-names></string-name></person-group><article-title>The impact of pharmaceutical innovation on the burden of disease in Canada, 2000&#8211;2016</article-title>. <source>SSM Popul Health</source>. <year>2019</year>;<volume>8</volume>:<fpage>100457</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1016/J.SSMPH.2019.100457</pub-id><pub-id pub-id-type="pmid">31440578</pub-id><pub-id pub-id-type="pmcid">PMC6698939</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lichtenberg</surname><given-names>FR.</given-names></string-name></person-group><article-title>The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996&#8211;2019</article-title>. <source>Swiss J Econ Stat</source>. <year>2022</year>;<volume>158</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>24</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1186/S41937-022-00086-4/TABLES/8</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kirzinger</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Montero</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sparks</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Valdes</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Hamel</surname><given-names>L.</given-names></string-name></person-group><article-title>Public opinion on prescription drugs and their prices</article-title>. <source>KFF</source>. Published August 21, <year>2023</year>. Accessed November 3, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.kff.org/health-costs/poll-finding/public-opinion-on-prescription-drugs-and-their-prices/" ext-link-type="uri">https://www.kff.org/health-costs/poll-finding/public-opinion-on-prescription-drugs-and-their-prices/</ext-link></mixed-citation></ref><ref id="CIT0006"><label>6.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Aitken</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kleinrock</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Pritchett</surname><given-names>J.</given-names></string-name></person-group><source>The Use of Medicines in the U.S. 2022: Usage and Spending Trends and Outlook to 2026</source>. <publisher-name>IQVIA</publisher-name>; <year>2022</year>.</mixed-citation></ref><ref id="CIT0007"><label>7.</label><mixed-citation publication-type="journal"><collab>Centers for Medicare and Medicaid Services</collab>. <article-title>NHE fact sheet</article-title>. Accessed November 3, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet" ext-link-type="uri">https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet</ext-link></mixed-citation></ref><ref id="CIT0008"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Johnson</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Bootman</surname><given-names>JL.</given-names></string-name></person-group><article-title>Drug-related morbidity and mortality and the economic impact of pharmaceutical care</article-title>. <source>Am J Health-Syst Pharm</source>. <year>1997</year>;<volume>54</volume>(<issue>5</issue>):<fpage>554</fpage>-<lpage>558</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1093/ajhp/54.5.554</pub-id><pub-id pub-id-type="pmid">9066865</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hodkinson</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tyler</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Ashcroft</surname><given-names>DM</given-names></string-name></person-group>, <etal>et al</etal><article-title>Preventable medication harm across health care settings: a systematic review and meta-analysis</article-title>. <source>BMC Med</source>. <year>2020</year>;<volume>18</volume>(<issue>1</issue>):<fpage>313</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1186/s12916-020-01774-9/tables/3</pub-id><pub-id pub-id-type="pmid">33153451</pub-id><pub-id pub-id-type="pmcid">PMC7646069</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10.</label><mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>. <article-title>Medication safety program</article-title>. Published <year>2024</year>. Accessed September 11, 2024.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/medication-safety/about/index.html?CDC_AAref_Val=" ext-link-type="uri">https://www.cdc.gov/medication-safety/about/index.html?CDC_AAref_Val=</ext-link><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/medicationsafety/adult_adversedrugevents.html" ext-link-type="uri">https://www.cdc.gov/medicationsafety/adult_adversedrugevents.html</ext-link></mixed-citation></ref><ref id="CIT0011"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Budnitz</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Lovegrove</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Shehab</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Richards</surname><given-names>C.</given-names></string-name></person-group><article-title>Emergency hospitalizations for adverse drug events in older Americans</article-title>. <source>N Engl J Med</source>. <year>2011</year>;<volume>365</volume>(<issue>21</issue>):<fpage>2002</fpage>-<lpage>2012</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1056/NEJMsa1103053</pub-id><pub-id pub-id-type="pmid">22111719</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tangiisuran</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Gozzoli</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Davies</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Rajkumar</surname><given-names>C.</given-names></string-name></person-group><article-title>Adverse drug reactions in older people</article-title>. <source>Rev Clin Gerontol</source>. <year>2010</year>;<volume>20</volume>(<issue>3</issue>):<fpage>246</fpage>-<lpage>259</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1017/S0959259810000171</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13.</label><mixed-citation publication-type="journal"><collab>Patient Safety Network</collab>. Medication errors and adverse drug events. Published September 7, <year>2019</year>. Accessed November 3, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://psnet.ahrq.gov/primer/medication-errors-and-adverse-drug-events" ext-link-type="uri">https://psnet.ahrq.gov/primer/medication-errors-and-adverse-drug-events</ext-link></mixed-citation></ref><ref id="CIT0014"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Eckel</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Jew</surname><given-names>RK.</given-names></string-name></person-group><article-title>The medication-use process: now as ever, pharmacy&#8217;s domain</article-title>. <source>Am J Health-Syst Pharm</source>. <year>2022</year>;<volume>79</volume>(<issue>4</issue>):<fpage>205</fpage>-<lpage>206</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1093/ajhp/ZXAB448</pub-id><pub-id pub-id-type="pmid">34849543</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vogenberg</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Benjamin</surname><given-names>D.</given-names></string-name></person-group><article-title>The medication-use process and the importance of mastering fundamentals</article-title>. <source>Pharm Ther.</source><year>2011</year>;<volume>36</volume>(<issue>10</issue>):<fpage>651</fpage>-<lpage>652</lpage>.<pub-id pub-id-type="pmcid">PMC3278147</pub-id><pub-id pub-id-type="pmid">22346298</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Cierniak</surname><given-names>K.</given-names></string-name></person-group><article-title>Integrating packing, storage, and disposal options into the medication use system</article-title>. In: <person-group person-group-type="editor"><string-name name-style="western"><surname>Chan</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Eby</surname><given-names>M</given-names></string-name></person-group>, eds. <source>Packaging, Storage, and Disposal Options to Enhance Opioid Safety&#8212;Exploring the Path Forward</source>. <publisher-name>Food and Drug Administration</publisher-name>; <year>2017</year>:<fpage>1</fpage>-<lpage>32</lpage>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.fda.gov/media/109538/download" ext-link-type="uri">https://www.fda.gov/media/109538/download</ext-link></mixed-citation></ref><ref id="CIT0017"><label>17.</label><mixed-citation publication-type="book"><collab>Committee on Identifying and Preventing Medication Errors</collab>. <article-title>Overview of the drug development, regulation, distribution, and use system</article-title>. In: <person-group person-group-type="editor"><string-name name-style="western"><surname>Aspden</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Wolcott</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Bootman</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Cronenwett</surname><given-names>LR</given-names></string-name></person-group>, eds. <source>Preventing Medication Errors</source>. <publisher-name>National Academies Press</publisher-name>; <year>2007</year>: <fpage>50</fpage>-<lpage>104</lpage>.</mixed-citation></ref><ref id="CIT0018"><label>18.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Haaijer-Ruskamp</surname><given-names>FM</given-names></string-name>, <string-name name-style="western"><surname>Hemmink</surname><given-names>E.</given-names></string-name></person-group><article-title>The social aspects of drug use</article-title>. In: <person-group person-group-type="editor"><string-name name-style="western"><surname>Dukes</surname><given-names>MNG</given-names></string-name></person-group>, ed. <source>Drug Utilization Studies: Methods and Uses</source>. <publisher-name>World Health Organization</publisher-name>; <year>1993</year>: <fpage>97</fpage>-<lpage>124</lpage>.</mixed-citation></ref><ref id="CIT0019"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Afanasjeva</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Burk</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Cunningham</surname><given-names>F</given-names></string-name></person-group>, <etal>et al</etal><article-title>ASHP Guidelines on Medication-Use Evaluation</article-title>. <source>Am J Health-Syst Pharm</source>. <year>2021</year>;<volume>78</volume>(<issue>2</issue>):<fpage>168</fpage>-<lpage>175</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1093/ajhp/zxaa393</pub-id><pub-id pub-id-type="pmid">33399190</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Almanie</surname><given-names>S.</given-names></string-name></person-group><source>Economic Impact of Waste in Prescribing, Dispensing, and Medication Consumption in the United States</source>. MS thesis. <publisher-name>Virginia Commonwealth University</publisher-name>; <year>2015</year>.</mixed-citation></ref><ref id="CIT0021"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Poitras</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Maltais</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Bestard-Denomm&#233;</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Stewart</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Fortin</surname><given-names>M.</given-names></string-name></person-group><article-title>What are the effective elements in patient-centered and multimorbidity care? A scoping review</article-title>. <source>BMC Health Serv Res</source>. <year>2018</year>;<volume>18</volume>(<issue>1</issue>):<fpage>446</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1186/s12913-018-3213-8</pub-id><pub-id pub-id-type="pmid">29898713</pub-id><pub-id pub-id-type="pmcid">PMC6001147</pub-id></mixed-citation></ref><ref id="CIT0022"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vest</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Gazda</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Schenkat</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Eckel</surname><given-names>SF.</given-names></string-name></person-group><article-title>Practice-enhancing publications about the medication-use process in 2018</article-title>. <source>Am J Health-Syst Pharm</source>. <year>2020</year>;<volume>77</volume>(<issue>10</issue>):<fpage>759</fpage>-<lpage>770</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1093/ajhp/zxaa057</pub-id><pub-id pub-id-type="pmid">32378716</pub-id></mixed-citation></ref><ref id="CIT0023"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vest</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Gazda</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Schenkat</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Eckel</surname><given-names>SF.</given-names></string-name></person-group><article-title>Practice-enhancing publications about the medication use process in 2017</article-title>. <source>Am J Health-Syst Pharm</source>. <year>2019</year>;<volume>76</volume>(<issue>10</issue>):<fpage>667</fpage>-<lpage>676</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1093/ajhp/zxz028</pub-id><pub-id pub-id-type="pmid">30933253</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vest</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Gazda</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Neil</surname><given-names>DP</given-names></string-name>, <string-name name-style="western"><surname>Schenkat</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Eckel</surname><given-names>SF.</given-names></string-name></person-group><article-title>Practice-enhancing publications about the medication-use process in 2020</article-title>. <source>Am J Health-Syst Pharm</source>. <year>2022</year>;<volume>79</volume>(<issue>4</issue>):<fpage>244</fpage>-<lpage>267</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1093/ajhp/zxab428</pub-id><pub-id pub-id-type="pmid">34758060</pub-id></mixed-citation></ref><ref id="CIT0025"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moore</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Jenkins</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Poppe</surname><given-names>LB</given-names></string-name>, <string-name name-style="western"><surname>Rowe</surname><given-names>EC</given-names></string-name>, <string-name name-style="western"><surname>Eckel</surname><given-names>SF.</given-names></string-name></person-group><article-title>Significant publications about the medication use process in 2012</article-title>. <source>J Pharm Pract</source>. <year>2015</year>;<volume>28</volume>(<issue>4</issue>):<fpage>387</fpage>-<lpage>397</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1177/0897190013519821</pub-id><pub-id pub-id-type="pmid">24626735</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Cipolle</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Strand</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Morley</surname><given-names>PC.</given-names></string-name></person-group><source>Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management Services</source>. <edition>3</edition>rd ed. <publisher-name>McGraw-Hill Medical</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="CIT0027"><label>27.</label><mixed-citation publication-type="journal"><collab>Minnesota Pharmacists Association</collab>; <article-title>College of Pharmacy, University of Minnesota. Minnesota Pharmacy Practice-Based Research Network</article-title>. Accessed November 3, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://cdn.ymaws.com/www.mpha.org/resource/resmgr/imported/PBRN/index.html" ext-link-type="uri">https://cdn.ymaws.com/www.mpha.org/resource/resmgr/imported/PBRN/index.html</ext-link></mixed-citation></ref><ref id="CIT0028"><label>28.</label><mixed-citation publication-type="journal"><collab>College of Pharmacy, Purdue University</collab>. <article-title>Medication Safety Research Network of Indiana</article-title>. Accessed November 3, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.pharmacy.purdue.edu/rx-safenet/aboutus/" ext-link-type="uri">https://www.pharmacy.purdue.edu/rx-safenet/aboutus/</ext-link></mixed-citation></ref><ref id="CIT0029"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lipowski</surname><given-names>EE.</given-names></string-name></person-group><article-title>Pharmacy practice-based research networks: why, what, who, and how</article-title>. <source>J Am Pharm Assoc</source>. <year>2008</year>;<volume>48</volume>(<issue>2</issue>):<fpage>142</fpage>-<lpage>152</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1331/JAPHA.2008.08018</pub-id><pub-id pub-id-type="pmid">18359727</pub-id></mixed-citation></ref><ref id="CIT0030"><label>30.</label><mixed-citation publication-type="journal"><collab>Community Pharmacy Enhanced Services Network</collab>. <article-title>About CPESN USA</article-title>. Accessed November 3, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://cpesn.com/about-cpesn-usa" ext-link-type="uri">https://cpesn.com/about-cpesn-usa</ext-link></mixed-citation></ref><ref id="CIT0031"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Patel</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hemmeger</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kozak</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Gernant</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Snyder</surname><given-names>ME.</given-names></string-name></person-group><article-title>Community pharmacist participation in a practice-based research network: a report from the Medication Safety Research Network of Indiana (Rx-SafeNet)</article-title>. <source>J Am Pharm Assoc</source>. <year>2015</year>;<volume>55</volume>(<issue>6</issue>):<fpage>649</fpage>-<lpage>655</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1331/JAPHA.2015.14244</pub-id><pub-id pub-id-type="pmcid">PMC5536969</pub-id><pub-id pub-id-type="pmid">26547598</pub-id></mixed-citation></ref><ref id="CIT0032"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kozak</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Gernant</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Hemmeger</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Snyder</surname><given-names>ME.</given-names></string-name></person-group><article-title>Lesson learned in the growth and maturation stages of a community pharmacy practice-based research network: experiences of the Medication Safety Research Network of Indiana (Rx-SafeNet)</article-title>. <source>Innov Pharm</source>. <year>2015</year>;<volume>6</volume>(<issue>2</issue>):<fpage>203</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.24926/IIP.V6I2.385</pub-id><pub-id pub-id-type="pmid">28163979</pub-id><pub-id pub-id-type="pmcid">PMC5287575</pub-id></mixed-citation></ref><ref id="CIT0033"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Andrade</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Cheetham</surname><given-names>TC</given-names></string-name></person-group>, <etal>et al</etal><article-title>Medication Exposure in Pregnancy Risk Evaluation Program</article-title>. <source>Matern Child Health J</source>. <year>2012</year>;<volume>16</volume>(<issue>7</issue>):<fpage>1349</fpage>-<lpage>1354</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1007/s10995-011-0902-x</pub-id><pub-id pub-id-type="pmid">22002179</pub-id><pub-id pub-id-type="pmcid">PMC3361624</pub-id></mixed-citation></ref><ref id="CIT0034"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Andrade</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Scott</surname><given-names>PE</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>RL</given-names></string-name></person-group>, <etal>et al</etal><article-title>Validity of health plan and birth certificate data for pregnancy research</article-title>. <source>Pharmacoepidemiol Drug Saf</source>. <year>2013</year>;<volume>22</volume>(<issue>1</issue>):<fpage>7</fpage>-<lpage>15</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1002/pds.3319</pub-id><pub-id pub-id-type="pmid">22753079</pub-id><pub-id pub-id-type="pmcid">PMC3492503</pub-id></mixed-citation></ref><ref id="CIT0035"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Go</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Magid</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Wells</surname><given-names>B</given-names></string-name></person-group>, <etal>et al</etal><article-title>The Cardiovascular Research Network</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>. <year>2008</year>;<volume>1</volume>(<issue>2</issue>):<fpage>138</fpage>-<lpage>147</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.108.801654</pub-id><pub-id pub-id-type="pmid">20031802</pub-id></mixed-citation></ref><ref id="CIT0036"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ross</surname><given-names>TR</given-names></string-name>, <string-name name-style="western"><surname>Ng</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>JS</given-names></string-name></person-group>, <etal>et al</etal><article-title>The HMO Research Network Virtual Data Warehouse: a public data model to support collaboration</article-title>. <source>EGEMS</source>. <year>2014</year>;<volume>2</volume>(<issue>1</issue>):<fpage>1049</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.13063/2327-9214.1049</pub-id><pub-id pub-id-type="pmid">25848584</pub-id><pub-id pub-id-type="pmcid">PMC4371424</pub-id></mixed-citation></ref><ref id="CIT0037"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gernant</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Adeoye-Olatunde</surname><given-names>OA</given-names></string-name>, <string-name name-style="western"><surname>Murawski</surname><given-names>MM</given-names></string-name></person-group>, <etal>et al</etal><article-title>Experiences applying technology to overcome common challenges in pharmacy practice-based research in the United States</article-title>. <source>Pharmacy</source>. <year>2020</year>;<volume>8</volume>(<issue>2</issue>):<fpage>93</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.3390/pharmacy8020093</pub-id><pub-id pub-id-type="pmid">32486241</pub-id><pub-id pub-id-type="pmcid">PMC7356027</pub-id></mixed-citation></ref><ref id="CIT0038"><label>38.</label><mixed-citation publication-type="journal"><collab>National Center for Health Statistics, Centers for Disease Control and Prevention</collab>. <article-title>Therapeutic drug use</article-title>. Accessed November 3, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/nchs/fastats/drug-use-therapeutic.htm" ext-link-type="uri">https://www.cdc.gov/nchs/fastats/drug-use-therapeutic.htm</ext-link></mixed-citation></ref><ref id="CIT0039"><label>39.</label><mixed-citation publication-type="book"><collab>IQVIA Institute for Human Data Science</collab>. <source>Medicine Use and Spending in the U.S.: A Review of 2018 and Outlook to 2023</source>. <publisher-name>IQVIA</publisher-name>; <year>2019</year>.</mixed-citation></ref><ref id="CIT0040"><label>40.</label><mixed-citation publication-type="journal"><collab>Food and Drug Administration</collab>. <article-title>Real-world evidence</article-title>. Accessed November 3, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence" ext-link-type="uri">https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence</ext-link></mixed-citation></ref><ref id="CIT0041"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Leape</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Berwick</surname><given-names>DM.</given-names></string-name></person-group><article-title>Five years after to err is human: what have we learned</article-title>? <source>JAMA</source>. <year>2005</year>;<volume>293</volume>(<issue>19</issue>):<fpage>2384</fpage>-<lpage>2390</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1001/jama.293.19.2384</pub-id><pub-id pub-id-type="pmid">15900009</pub-id></mixed-citation></ref><ref id="CIT0042"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kelly</surname><given-names>WN</given-names></string-name>, <string-name name-style="western"><surname>Rucker</surname><given-names>TD.</given-names></string-name></person-group><article-title>Compelling features of a safe medication-use system</article-title>. <source>Am J Health-Syst Pharm</source>. <year>2006</year>;<volume>63</volume>(<issue>15</issue>):<fpage>1461</fpage>-<lpage>1468</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.2146/ajhp050343</pub-id><pub-id pub-id-type="pmid">16849713</pub-id></mixed-citation></ref><ref id="CIT0043"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vogt</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Lafata</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Tolsma</surname><given-names>DD</given-names></string-name>, <string-name name-style="western"><surname>Greene</surname><given-names>SM.</given-names></string-name></person-group><article-title>The role of research in integrated health care systems: the HMO Research Network</article-title>. <source>Perm J</source>. <year>2004</year>;<volume>8</volume>(<issue>4</issue>):<fpage>10</fpage>-<lpage>17</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.7812/TPP/04.906</pub-id><pub-id pub-id-type="pmcid">PMC4690686</pub-id><pub-id pub-id-type="pmid">26705313</pub-id></mixed-citation></ref><ref id="CIT0044"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wagner</surname><given-names>EH</given-names></string-name>, <string-name name-style="western"><surname>Greene</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Hart</surname><given-names>G</given-names></string-name></person-group>, <etal>et al</etal><article-title>Building a research consortium of large health systems: the Cancer Research Network</article-title>. <source>J Natl Cancer Inst Monogr</source>. <year>2005</year>;(<issue>35</issue>):<fpage>3</fpage>-<lpage>11</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1093/jncimonographs/LGI032</pub-id><pub-id pub-id-type="pmid">16287880</pub-id></mixed-citation></ref><ref id="CIT0045"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chubak</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ziebell</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Greenlee</surname><given-names>RT</given-names></string-name></person-group>, <etal>et al</etal><article-title>The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations</article-title>. <source>Cancer Causes Control</source>. <year>2016</year>;<volume>27</volume>(<issue>11</issue>):<fpage>1315</fpage>-<lpage>1323</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1007/s10552-016-0808-4</pub-id><pub-id pub-id-type="pmid">27639398</pub-id><pub-id pub-id-type="pmcid">PMC5868750</pub-id></mixed-citation></ref><ref id="CIT0046"><label>46.</label><mixed-citation publication-type="book"><collab>Institute of Medicine Roundtable on Evidence-Based Medicine</collab>. <article-title>Developing the test bed&#8212;linking integrated service delivery systems</article-title>. In: <person-group person-group-type="editor"><string-name name-style="western"><surname>Olsen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Aisner</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>McGinnis</surname><given-names>JM</given-names></string-name></person-group>, eds. <source>The Learning Healthcare System: Workshop Summary</source>. <publisher-name>National Academies Press</publisher-name>; <year>2007</year>:<fpage>217</fpage>-<lpage>242</lpage>.<pub-id pub-id-type="pmid">21452449</pub-id></mixed-citation></ref><ref id="CIT0047"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Coleman</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Stewart</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Waitzfelder</surname><given-names>BE</given-names></string-name></person-group>, <etal>et al</etal><article-title>Racial-ethnic differences in psychiatric diagnoses and treatment across 11 health care systems in the Mental Health Research Network</article-title>. <source>Psychiatr Serv</source>. <year>2016</year>;<volume>67</volume>(<issue>7</issue>):<fpage>749</fpage>-<lpage>757</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1176/appi.ps.201500217</pub-id><pub-id pub-id-type="pmid">27079987</pub-id><pub-id pub-id-type="pmcid">PMC4930394</pub-id></mixed-citation></ref><ref id="CIT0048"><label>48.</label><mixed-citation publication-type="journal"><collab>Mental Health Research Network</collab>. <article-title>About MHRN</article-title>. Accessed November 3, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://mhresearchnetwork.org/" ext-link-type="uri">https://mhresearchnetwork.org/</ext-link></mixed-citation></ref><ref id="CIT0049"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Baggs</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gee</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lewis</surname><given-names>E</given-names></string-name></person-group>, <etal>et al</etal><article-title>The Vaccine Safety Datalink: a model for monitoring immunization safety</article-title>. <source>Pediatrics</source>. <year>2011</year>;<volume>127</volume>(<issue>suppl 1</issue>):<fpage>S45</fpage>-<lpage>S53</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1542/peds.2010-1722H</pub-id><pub-id pub-id-type="pmid">21502240</pub-id></mixed-citation></ref><ref id="CIT0050"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chen</surname><given-names>RT</given-names></string-name>, <string-name name-style="western"><surname>Glasser</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Rhodes</surname><given-names>PH</given-names></string-name></person-group>, <etal>et al</etal><article-title>Vaccine Safety Datalink Project: a new tool for improving vaccine safety monitoring in the United States</article-title>. <source>Pediatrics</source>. <year>1997</year>;<volume>99</volume>(<issue>6</issue>):<fpage>765</fpage>-<lpage>773</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1542/peds.99.6.765</pub-id><pub-id pub-id-type="pmid">9164767</pub-id></mixed-citation></ref><ref id="CIT0051"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McNeil</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Gee</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Weintraub</surname><given-names>ES</given-names></string-name></person-group>, <etal>et al</etal><article-title>The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety</article-title>. <source>Vaccine</source>. <year>2014</year>;<volume>32</volume>(<issue>42</issue>):<fpage>5390</fpage>-<lpage>5398</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1016/j.vaccine.2014.07.073</pub-id><pub-id pub-id-type="pmid">25108215</pub-id><pub-id pub-id-type="pmcid">PMC6727851</pub-id></mixed-citation></ref><ref id="CIT0052"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McMahill-Walraven</surname><given-names>CN</given-names></string-name>, <string-name name-style="western"><surname>Kent</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Panozzo</surname><given-names>CA</given-names></string-name></person-group>, <etal>et al</etal><article-title>Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to evaluate patterns of care</article-title>. <source>J Manag Care Spec Pharm</source>. <year>2019</year>;<volume>25</volume>(<issue>11</issue>):<fpage>1156</fpage>-<lpage>1161</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.18553/jmcp.2019.19041</pub-id><pub-id pub-id-type="pmid">31397619</pub-id><pub-id pub-id-type="pmcid">PMC10398299</pub-id></mixed-citation></ref><ref id="CIT0053"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Findlay</surname><given-names>S.</given-names></string-name></person-group><article-title>Health Policy Brief: The FDA&#8217;s Sentinel Initiative</article-title>. <source>Health Affairs</source>. Published June 4, 2015. Accessed November 3, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.healthaffairs.org/do/10.1377/hpb20150604.936915/" ext-link-type="uri">https://www.healthaffairs.org/do/10.1377/hpb20150604.936915/</ext-link></mixed-citation></ref><ref id="CIT0054"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Behrman</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Benner</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>McClellan</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Woodcock</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Platt</surname><given-names>R.</given-names></string-name></person-group><article-title>Developing the Sentinel system&#8212;a national resource for evidence development</article-title>. <source>N Engl J Med</source>. <year>2011</year>;<volume>364</volume>(<issue>6</issue>):<fpage>498</fpage>-<lpage>499</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1056/NEJMP1014427</pub-id><pub-id pub-id-type="pmid">21226658</pub-id></mixed-citation></ref><ref id="CIT0055"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hornbrook</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Hart</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Ellis</surname><given-names>JL</given-names></string-name></person-group>, <etal>et al</etal><article-title>Building a virtual cancer research organization</article-title>. <source>J Natl Cancer Inst Monogr</source>. <year>2005</year>;(<issue>35</issue>):<fpage>12</fpage>-<lpage>25</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1093/jncimonographs/LGI033</pub-id><pub-id pub-id-type="pmid">16287881</pub-id></mixed-citation></ref><ref id="CIT0056"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rahm</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Ladd</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Burnett-Hartman</surname><given-names>AN</given-names></string-name></person-group>, <etal>et al</etal><article-title>The Healthcare Systems Research Network (HCSRN) as an environment for dissemination and implementation research: a case study of developing a multi-site research study in precision medicine. <italic toggle="yes">EGEMS</italic></article-title>. <year>2019</year>;<volume>7</volume>(<issue>1</issue>):<fpage>16</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.5334/egems.283</pub-id><pub-id pub-id-type="pmcid">PMC6460496</pub-id><pub-id pub-id-type="pmid">30984796</pub-id></mixed-citation></ref><ref id="CIT0057"><label>57.</label><mixed-citation publication-type="journal"><collab>Health Care Systems Research Network</collab>. About. Accessed <comment>November 3, 2023</comment>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://hcsrn.org/members/" ext-link-type="uri">https://hcsrn.org/members/</ext-link></mixed-citation></ref><ref id="CIT0058"><label>58.</label><mixed-citation publication-type="journal"><collab>The National Patient-Centered Clinical Research Network</collab>. <article-title>PCORnet</article-title>. Accessed November 3, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pcornet.org/data/" ext-link-type="uri">https://pcornet.org/data/</ext-link></mixed-citation></ref><ref id="CIT0059"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Forrest</surname><given-names>CB</given-names></string-name>, <string-name name-style="western"><surname>McTigue</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Hernandez</surname><given-names>AF</given-names></string-name></person-group>, <etal>et al</etal><article-title>PCORnet 2020: current state, accomplishments, and future directions</article-title>. <source>J Clin Epidemiol</source>. <year>2021</year>;<volume>129</volume>:<fpage>60</fpage>-<lpage>67</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1016/j.jclinepi.2020.09.036</pub-id><pub-id pub-id-type="pmid">33002635</pub-id><pub-id pub-id-type="pmcid">PMC7521354</pub-id></mixed-citation></ref><ref id="CIT0060"><label>60.</label><mixed-citation publication-type="book"><collab>Health Care Systems Research Network</collab>. <source>Virtual Data Warehouse Data Specifications</source>. <publisher-name>Health Care Systems Research Network</publisher-name>; <year>2020</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://hcsrn.org/wp-content/uploads/2021/12/VDWSpecifications.pdf" ext-link-type="uri">https://hcsrn.org/wp-content/uploads/2021/12/VDWSpecifications.pdf</ext-link></mixed-citation></ref><ref id="CIT0061"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Roblin</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rubenstein</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Tavel</surname><given-names>H</given-names></string-name></person-group>, <etal>et al</etal><article-title>Development of a common data model for a multisite and multiyear study of virtual visit implementation: a case study</article-title>. <source>Med Care</source>. <year>2023</year>;<volume>61</volume>(<issue>suppl 1</issue>):<fpage>S54</fpage>-<lpage>S61</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1097/MLR.0000000000001834</pub-id><pub-id pub-id-type="pmid">36893419</pub-id><pub-id pub-id-type="pmcid">PMC9994571</pub-id></mixed-citation></ref><ref id="CIT0062"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Simon</surname><given-names>GE</given-names></string-name>, <string-name name-style="western"><surname>Shortreed</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>E</given-names></string-name></person-group>, <etal>et al</etal><article-title>Predicting risk of suicidal behavior from insurance claims data vs. linked data from insurance claims and electronic health records</article-title>. <source>Pharmacoepidemiol Drug Saf</source>. <year>2024</year>;<volume>33</volume>(<issue>1</issue>):<fpage>e5734</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1002/pds.5734</pub-id><pub-id pub-id-type="pmid">38112287</pub-id><pub-id pub-id-type="pmcid">PMC10843611</pub-id></mixed-citation></ref><ref id="CIT0063"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boggs</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Simon</surname><given-names>GE</given-names></string-name>, <string-name name-style="western"><surname>Beck</surname><given-names>A</given-names></string-name></person-group>, <etal>et al</etal><article-title>Are people who die by intentional medication poisoning dispensed those medications in the year prior to death</article-title>? <source>Arch Suicide Res</source>. <year>2023</year>;<volume>27</volume>(<issue>3</issue>):<fpage>1083</fpage>-<lpage>1090</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1080/13811118.2022.2072253</pub-id><pub-id pub-id-type="pmid">35579399</pub-id><pub-id pub-id-type="pmcid">PMC9762134</pub-id></mixed-citation></ref><ref id="CIT0064"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Scherrer</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Salas</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Grucza</surname><given-names>R</given-names></string-name></person-group>, <etal>et al</etal><article-title>Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder</article-title>. <source>Drug Alcohol Depend Rep.</source><year>2022</year>;<volume>5</volume>:<fpage>100122</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1016/j.dadr.2022.100122</pub-id><pub-id pub-id-type="pmid">36844161</pub-id><pub-id pub-id-type="pmcid">PMC9949323</pub-id></mixed-citation></ref><ref id="CIT0065"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lo Re</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Dutcher</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Connolly</surname><given-names>JG</given-names></string-name></person-group>, <etal>et al</etal><article-title>Association of COVID-19 vs influenza with risk of arterial and venous thrombotic events among hospitalized patients</article-title>. <source>JAMA</source>. <year>2022</year>;<volume>328</volume>(<issue>7</issue>):<fpage>637</fpage>-<lpage>651</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1001/jama.2022.13072</pub-id><pub-id pub-id-type="pmid">35972486</pub-id><pub-id pub-id-type="pmcid">PMC9382447</pub-id></mixed-citation></ref><ref id="CIT0066"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Singh</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Cocoros</surname><given-names>NM</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name></person-group>, <etal>et al</etal><article-title>Developing a program to educate and sensitize caregivers to reduce the inappropriate prescription burden in the elderly with Alzheimer&#8217;s disease (D-PRESCRIBE-AD): trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial</article-title>. <source>PLoS One</source>. <year>2024</year>;<volume>19</volume>(<issue>2</issue>):<fpage>e0297562</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0297562</pub-id><pub-id pub-id-type="pmid">38346025</pub-id><pub-id pub-id-type="pmcid">PMC10861034</pub-id></mixed-citation></ref><ref id="CIT0067"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Margolis</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Bergdall</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Crain</surname><given-names>AL</given-names></string-name></person-group>, <etal>et al</etal><article-title>Comparing pharmacist-led telehealth care and clinic-based care for uncontrolled high blood pressure: the Hyperlink 3 pragmatic cluster-randomized trial</article-title>. <source>Hypertension</source>. <year>2022</year>;<volume>79</volume>(<issue>12</issue>):<fpage>2708</fpage>-<lpage>2720</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.122.19816</pub-id><pub-id pub-id-type="pmid">36281763</pub-id><pub-id pub-id-type="pmcid">PMC9649877</pub-id></mixed-citation></ref><ref id="CIT0068"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rossom</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Crain</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Connor</surname><given-names>PJ</given-names></string-name></person-group>, <etal>et al</etal><article-title>Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care</article-title>. <source>Contemp Clin Trials</source>. <year>2023</year>;<volume>124</volume>:<fpage>107012</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1016/j.cct.2022.107012</pub-id><pub-id pub-id-type="pmid">36402275</pub-id><pub-id pub-id-type="pmcid">PMC9839646</pub-id></mixed-citation></ref><ref id="CIT0069"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rossom</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Crain</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Waring</surname><given-names>S</given-names></string-name></person-group>, <etal>et al</etal><article-title>Differential effects of an intervention to reduce cardiovascular risk for patients with bipolar disorder, schizoaffective disorder, or schizophrenia: a randomized clinical trial</article-title>. <source>J Clin Psychiatry</source>. <year>2023</year>;<volume>84</volume>(<issue>4</issue>):<fpage>22m14710</fpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.4088/JCP.22M14710</pub-id><pub-id pub-id-type="pmcid">PMC10793875</pub-id><pub-id pub-id-type="pmid">37428030</pub-id></mixed-citation></ref><ref id="CIT0070"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fischer</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Stedman</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Lii</surname><given-names>J</given-names></string-name></person-group>, <etal>et al</etal><article-title>Primary medication non-adherence: analysis of 195,930 electronic prescriptions</article-title>. <source>J Gen Intern Med</source>. <year>2010</year>;<volume>25</volume>(<issue>4</issue>):<fpage>284</fpage>-<lpage>290</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1007/s11606-010-1253-9</pub-id><pub-id pub-id-type="pmid">20131023</pub-id><pub-id pub-id-type="pmcid">PMC2842539</pub-id></mixed-citation></ref><ref id="CIT0071"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Karter</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Moffet</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>Ahmed</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Schmittdiel</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Selby</surname><given-names>JV.</given-names></string-name></person-group><article-title>New prescription medication gaps: a comprehensive measure of adherence to new prescriptions</article-title>. <source>Health Serv Res.</source><year>2009</year>;<volume>44</volume>(<issue>5 Pt 1</issue>):<fpage>1640</fpage>-<lpage>1661</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1111/j.1475-6773.2009.00989.x</pub-id><pub-id pub-id-type="pmid">19500161</pub-id><pub-id pub-id-type="pmcid">PMC2754552</pub-id></mixed-citation></ref><ref id="CIT0072"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Raebel</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Schmittdiel</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Karter</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Konieczny</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Steiner</surname><given-names>JF.</given-names></string-name></person-group><article-title>Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases</article-title>. <source>Med Care.</source><year>2013</year>;<volume>51</volume>(<issue>8 suppl 3</issue>):<fpage>S11</fpage>-<lpage>S21</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1097/MLR.0b013e31829b1d2a</pub-id><pub-id pub-id-type="pmid">23774515</pub-id><pub-id pub-id-type="pmcid">PMC3727405</pub-id></mixed-citation></ref><ref id="CIT0073"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Brown</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Maro</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Nguyen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ball</surname><given-names>R.</given-names></string-name></person-group><article-title>Using and improving distributed data networks to generate actionable evidence: the case of real-world outcomes in the Food and Drug Administration&#8217;s Sentinel system</article-title>. <source>J Am Med Inform Assoc</source>. <year>2020</year>;<volume>27</volume>(<issue>5</issue>):<fpage>793</fpage>-<lpage>797</lpage>. doi: https://doi.org/<pub-id pub-id-type="doi">10.1093/jama/ocaa028</pub-id><pub-id pub-id-type="pmid">32279080</pub-id><pub-id pub-id-type="pmcid">PMC7647264</pub-id></mixed-citation></ref><ref id="CIT0074"><label>74.</label><mixed-citation publication-type="book"><collab>Health Care Systems Research Network</collab>. <source>HCSRN Virtual Data Warehouse Enrollment and Demographics Quality Assurance Report.</source><publisher-name>Health Care Systems Research Network</publisher-name>; <year>2024</year>.</mixed-citation></ref></ref-list></back></article></pmc-articleset>